Lyrica 50 mg/1

Pregabalin, the active ingredient in Lyrica 50 mg/1, is an anticonvulsant presented as a 50 mg/capsule for oral use. It is used to manage neuropathic pain, fibromyalgia, and partial onset seizures in adults. GNH USA supplies Lyrica 50 mg/1 as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies, and clinics worldwide.

Lyrica 50 mg/1 is a widely recognized medication for its efficacy in treating nerve-related pain and certain types of seizures. It is available in capsule form, making it convenient for oral administration.

Lyrica 50 mg/1 is primarily used to manage neuropathic pain and certain types of seizures. It is effective in treating a range of conditions, including:

- Neuropathic pain: Reduces pain caused by nerve damage, such as diabetic peripheral neuropathy and postherpetic neuralgia. - Fibromyalgia: Alleviates widespread musculoskeletal pain and fatigue associated with this condition. - Partial onset seizures: Used as adjunctive therapy to control seizures in adults and children aged 1 month and older.

Lyrica 50 mg/1 may cause various side effects, ranging from common to serious or rare.

Common Side Effects: - Dizziness: A frequent side effect that may affect balance and coordination. - Somnolence: Feeling sleepy or drowsy, which can impact daily activities. - Peripheral edema: Swelling in the extremities, such as the legs and feet. - Dry mouth: A common complaint that can be managed with adequate hydration. - Weight gain: Some patients may experience an increase in body weight.

Serious or Rare Side Effects: - Angioedema: Severe allergic reaction causing swelling of the face, lips, or throat. - Suicidal thoughts: Increased risk in patients with a history of depression or suicidal tendencies. - Visual disturbances: Blurred vision or other visual changes that may require medical attention. - Hypersensitivity reactions: Allergic reactions that can be severe and require immediate medical intervention.

Lyrica 50 mg/1 should be used with caution and under medical supervision. Important precautions include: - Dose adjustment: Required for patients with reduced kidney function to avoid excessive accumulation of the drug. - Discontinuation: Should be done gradually to prevent withdrawal symptoms such as seizures, anxiety, and insomnia. - Driving and operating machinery: Patients should be cautious as Lyrica may cause dizziness and drowsiness. - Alcohol consumption: Should be avoided as it can enhance the sedative effects of the medication. - Pregnancy: Should be used with caution, as it is classified as a pregnancy category C drug. - Store below 25°C: Keep in the original pack, protect from moisture.

Lyrica 50 mg/1 may interact with other medications, which can affect its efficacy and safety.

Major Interactions (Avoid): - Opioids: Concurrent use can enhance central nervous system depression, leading to respiratory depression and sedation. - Benzodiazepines: Increased risk of severe sedation and respiratory depression when used together. - Alcohol: Can exacerbate the sedative effects of Lyrica, leading to increased drowsiness and dizziness.

Moderate Interactions (Monitor Closely): - Antihistamines: May increase the sedative effects of Lyrica, requiring close monitoring. - Antidepressants: Some antidepressants can enhance the side effects of Lyrica, such as dizziness and drowsiness. - Antipsychotics: May increase the risk of sedation and other central nervous system side effects.